Home > Journals > Minerva Ginecologica > Past Issues > Articles online first > Minerva Ginecologica 2017 Apr 10

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints
Cite this article as

MINERVA GINECOLOGICA

A Journal on Obstetrics and Gynecology


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Scopus, Emerging Sources Citation Index


eTOC

 

Minerva Ginecologica 2017 Apr 10

DOI: 10.23736/S0026-4784.17.04063-1

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

Teratology of valproic acid: an updated review of the possible mediating mechanisms

Adalisa PONZANO, Gian M. TIBONI

Department of Medicine and Aging Sciences, University “G. d’Annunzio” of Chieti-Pescara, Chieti, Italy


PDF  


Valproic acid (VPA) is an anti-epileptic drug (AED) which is currently being investigated for its potential application in the treatment of several types of cancers, including solid and non-solid tumor. It is well known that prenatal exposure to VPA largely increases the risk for malformations and other developmental disorders. This review concentrates on clinical and experimental data on congenital anomalies attributed to maternal VPA exposure during. Particular emphasis is paid to the potential mechanisms underlying VPA-induced malformations. Although several mechanisms have been suggested, there appears to be no data in the literature in support of a single definitive mechanism for VPA-exposurerelated
fetal malformations.


KEY WORDS: Valproic acid - Teratogenesis - Mechanisms of teratogenic action

top of page

Publication History

Cite this article as

Ponzano A, Tiboni GM. Teratology of valproic acid: an updated review of the possible mediating mechanisms. Minerva Ginecol 2017 Apr 10. DOI: 10.23736/S0026-4784.17.04063-1 

Corresponding author e-mail

tiboni@unich.it